AI-10-49

N/A

Report date: 2023/03/21 15:18:13
NME

Base Information

Drug NameAI-10-49
Drug Alias NameAI-10-49
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCBFβ-SMMHC Fusion Protein inhibitors
TargetsCBFβ-SMMHC Fusion Protein
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Massachusetts Medical School
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Massachusetts Medical School
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A